Niall O'Donnell - 11 Nov 2022 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Director
Signature
/s/ Niall O'Donnell, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
11 Nov 2022
Net transactions value
-$5,956,855
Form type
4
Filing time
15 Nov 2022, 19:02:54 UTC
Previous filing
06 Jun 2022
Next filing
16 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Sale $3,481,410 -174,121 -9.1% $19.99 1,746,997 11 Nov 2022 By RiverVest Venture Fund IV, L.P. F1, F2
transaction MIRM Common Stock Sale $629,423 -32,109 -1.8% $19.60 1,714,888 14 Nov 2022 By RiverVest Venture Fund IV, L.P. F2, F3
transaction MIRM Common Stock Sale $1,846,022 -93,770 -5.5% $19.69 1,621,118 15 Nov 2022 By RiverVest Venture Fund IV, L.P. F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.95 to $20.28, inclusive. The reporting persons undertake to provide Mirum Pharmaceuticals, Inc., any security holder of Mirum Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3) and (4) to this Form 4.
F2 RiverVest Venture Partners IV, L.P. is the general partner of RiverVest Venture Fund IV, L.P. The Reporting Person is a manager of RiverVest Venture Partners IV, LLC, the sole general partner of RiverVest Venture Partners IV, L.P., and as a result may be deemed to share dispositive voting and investment power with respect to the shares held by RiverVest Venture Partners IV, L.P. The Reporting Person disclaims beneficial ownership of all shares held by RiverVest Venture Partners IV, L.P. except to the extent of his pecuniary interests therein.
F3 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.105 to $20.43, inclusive.
F4 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $20.32, inclusive.